JP2005502324A - 卵巣特異的遺伝子およびタンパク質 - Google Patents

卵巣特異的遺伝子およびタンパク質 Download PDF

Info

Publication number
JP2005502324A
JP2005502324A JP2002585597A JP2002585597A JP2005502324A JP 2005502324 A JP2005502324 A JP 2005502324A JP 2002585597 A JP2002585597 A JP 2002585597A JP 2002585597 A JP2002585597 A JP 2002585597A JP 2005502324 A JP2005502324 A JP 2005502324A
Authority
JP
Japan
Prior art keywords
peptide
protein
expression
modulator
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002585597A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005502324A5 (enExample
Inventor
マザック、マーティン、エム．
ワン、ペイ
バイ、ユーチェン
ウー、シウメイ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth LLC
Baylor College of Medicine
Original Assignee
Wyeth LLC
Baylor College of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth LLC, Baylor College of Medicine filed Critical Wyeth LLC
Publication of JP2005502324A publication Critical patent/JP2005502324A/ja
Publication of JP2005502324A5 publication Critical patent/JP2005502324A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1055—Protein x Protein interaction, e.g. two hybrid selection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP2002585597A 2001-04-27 2002-04-26 卵巣特異的遺伝子およびタンパク質 Pending JP2005502324A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/844,864 US20020042926A1 (en) 1998-10-28 2001-04-27 Ovary-specific genes and proteins
PCT/US2002/013245 WO2002088314A2 (en) 2001-04-27 2002-04-26 Ovary-specific genes and proteins

Publications (2)

Publication Number Publication Date
JP2005502324A true JP2005502324A (ja) 2005-01-27
JP2005502324A5 JP2005502324A5 (enExample) 2005-12-22

Family

ID=25293816

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002585597A Pending JP2005502324A (ja) 2001-04-27 2002-04-26 卵巣特異的遺伝子およびタンパク質

Country Status (4)

Country Link
US (2) US20020042926A1 (enExample)
JP (1) JP2005502324A (enExample)
CA (1) CA2445410A1 (enExample)
WO (1) WO2002088314A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020042926A1 (en) * 1998-10-28 2002-04-11 Matzuk Martin M. Ovary-specific genes and proteins
US20060079674A1 (en) * 1998-10-28 2006-04-13 Baylor College Of Medicine Wyeth Contraceptive targets
EP1124840A4 (en) * 1998-10-28 2002-07-17 Baylor College Medicine GENES AND PROTEINS SPECIFIC TO OVARIES
US7335737B2 (en) * 1998-10-28 2008-02-26 Baylor College Of Medicine Ovary-specific genes and proteins
US7803765B2 (en) 1999-05-05 2010-09-28 Phylogica Limited Methods of constructing biodiverse gene fragment libraries and biological modulators isolated therefrom
CA2568644C (en) * 2004-06-03 2015-11-24 Phylogica Limited Peptide modulators of cellular phenotype and bi-nucleic acid fragment library
CN122208585B (zh) * 2026-05-21 2026-07-31 内蒙古大学 一种肌酸处理提升华西牛超数排卵效率的调控方法及应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4736866B1 (en) * 1984-06-22 1988-04-12 Transgenic non-human mammals
US5661126A (en) * 1989-01-19 1997-08-26 The General Hospital Corporation Use of mullerian inhibiting substance for treating certain tumors and for modulating class I major histocompatibility antigen expression
WO1993019177A1 (en) * 1992-03-18 1993-09-30 The General Hospital Corporation FOUR NOVEL RECEPTORS OF THE TGF-β RECEPTOR FAMILY
US5563059A (en) * 1993-02-23 1996-10-08 Genentech, Inc. Use of human inhibin and human activin to increase the number of mature primate oocytes
WO1996030510A1 (en) * 1995-03-29 1996-10-03 Japan Tobacco Inc. Dna fragment, recombination vector containing the same, and method of the expression of alien gene with the use of the same
US6090620A (en) * 1995-12-29 2000-07-18 University Of Washington Genes and gene products related to Werner's syndrome
US6551795B1 (en) * 1998-02-18 2003-04-22 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
US6995251B1 (en) * 1999-10-28 2006-02-07 Baylor Ovary-specific genes and proteins
US20020042926A1 (en) * 1998-10-28 2002-04-11 Matzuk Martin M. Ovary-specific genes and proteins
EP1124840A4 (en) * 1998-10-28 2002-07-17 Baylor College Medicine GENES AND PROTEINS SPECIFIC TO OVARIES
ES2639020T3 (es) * 1998-11-27 2017-10-25 Ucb Pharma S.A. Composiciones y métodos para incrementar la mineralización de la substancia ósea

Also Published As

Publication number Publication date
WO2002088314A3 (en) 2003-09-12
WO2002088314A2 (en) 2002-11-07
US20020042926A1 (en) 2002-04-11
CA2445410A1 (en) 2002-11-07
US20040254132A1 (en) 2004-12-16

Similar Documents

Publication Publication Date Title
JPH09505735A (ja) ｐ５３−結合性ポリペプチド及びそれをコードするポリヌクレオチド
US7217811B2 (en) Human gene critical to fertility
US20080293116A1 (en) Ovary-specific genes and proteins
WO2002088314A2 (en) Ovary-specific genes and proteins
US20060275803A1 (en) Rat and mouse members of the CRISP family of genes
JP2004533229A (ja) 生殖能力に不可欠なヒト遺伝子
US6995251B1 (en) Ovary-specific genes and proteins
US20140038908A1 (en) Polynucleotides and Polypeptides Associated with Trophoblast Cell Death, Differentiation, Invasion and/or Cell Fusion and Turnover
AU774642B2 (en) Ovary-specific genes and proteins
AU2002259026A1 (en) Ovary-specific genes and proteins
US20060079674A1 (en) Contraceptive targets
US20060223099A1 (en) TEX14 compositions and modulators thereof to alter intercellular bridge development and function
JP2004528822A (ja) 筋特異的筋節カルシニューリン結合タンパク質（カルサルシン）に関する方法および組成物
US7300759B2 (en) Use of tramdorins in diagnostic and therapeutic methods
US6500940B1 (en) Lifeguard (LFG) polynucleotides and polypeptides and methods of use thereof
US7335737B2 (en) Ovary-specific genes and proteins
JP2006506952A (ja) 避妊ターゲット
EP1645562A1 (en) Ovary-specific genes and proteins
JP4435334B2 (ja) 胎盤型有機アニオントランスポーターとその遺伝子
AU2003228675A1 (en) Contraceptive targets
JP4300008B2 (ja) 新規タンパク質およびそのｄｎａ
JP2002504357A (ja) Ｈｅｌｉｏｓ遺伝子
US20030082650A1 (en) Great gene and protein
US20090233986A1 (en) Methods and compositions for using sax2
JP2004173677A (ja) 新規タンパク質およびそのｄｎａ

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20050419

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050419

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080107

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20080612